Back
Robert Half Vs. Intra-Cellular Therapies Industry Stock Comparison
Sell
29
RHI
Robert Half
Last Price:
69.13
Seasonality Move:
7.17%
Sell
37
ITCI
Intra-Cellular Therapies
Last Price:
71.85
Seasonality Move:
4.56%
Sell
29
Robert Half (RHI)
is a Sell
Is Robert Half a Buy, Sell or Hold?
- The current Robert Half [RHI] share price is $70.02. The Score for RHI is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- RHI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $72.30. The Score for ITCI is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RHI Stock Price Chart
What is Robert Half's stock price today?
-
The Robert Half share price today is $70.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RHI is experiencing slight selling pressure.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $72.30
The current trend is moderately bullish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.
RHI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.08 | Sell |
Relative Strength Index (14 RSI): | 33.81 | Sell |
Chaikin Money Flow: | -570689 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (70.34 - 76.84) | Sell |
Bollinger Bands (100): | (75.28 - 84.42) | Sell |
ITCI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.38 | Buy |
Relative Strength Index (14 RSI): | 53.26 | Buy |
Chaikin Money Flow: | -346308 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (66.59 - 73.79) | Buy |
Bollinger Bands (100): | (65.08 - 72.16) | Buy |
RHI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 70.54 | Sell |
20-day SMA: | 72.41 | Sell |
50-day SMA: | 76.81 | Sell |
200-day SMA: | 77.99 | Sell |
8-day EMA: | 70.63 | Sell |
20-day EMA: | 72.43 | Sell |
50-day EMA: | 75.59 | Sell |
200-day EMA: | 77.9 | Sell |
ITCI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 72.98 | Sell |
20-day SMA: | 70.61 | Buy |
50-day SMA: | 69.4 | Buy |
200-day SMA: | 62.33 | Buy |
8-day EMA: | 72.67 | Sell |
20-day EMA: | 71.32 | Buy |
50-day EMA: | 69.65 | Buy |
200-day EMA: | 64.15 | Buy |
Robert Half Earnings Growth & RHI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.89 per share, and an increase next year of $1.04 per share.
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.07 per share, an increase this year of $0.98 per share, and an increase next year of $1.45 per share.
Robert Half Technical Analysis
Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Intra-Cellular Therapies Technical Analysis
Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |